Nuix share price sinks 15% after swinging to half-year loss

This tech stock is having a poor start to the week after releasing its results.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nuix Ltd (ASX: NXL) share price is having a very disappointing start to the week.

At one stage, the investigative analytics and intelligence software provider's shares were down as much as 15% to $1.65.

This follows the release of the company's half-year results this morning.

A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.

Image source: Getty Images

Nuix shares sink on results day

  • Annualised contract value (ACV) up 17.3% to $199.6 million
  • Statutory revenue up 12.3% to $98.4 million
  • Statutory earnings before interest, tax, depreciation, and amortisation (EBITDA) down 17.6% to $17.2 million
  • Statutory loss after tax of $4.8 million (compared to $1.3 million profit)

What happened during the half?

For the six months ended 31 December, Nuix reported a 17.3% lift in ACV to $199.6 million. This was slightly above its guidance range and driven by strength in its existing customer base. All three key regions (North America, EMEA and Asia Pacific) reported double-digit ACV growth.

Things weren't quite as positive for its EBITDA, which fell 17.6% to $17.2 million largely because of legal costs. However, on an underlying basis, Nuix's EBITDA was up 12.8% to $28.4 million.

For the same reasons, Nuix recorded a net loss after tax of $4.8 million.

Nuix ended the half with cash on hand of $24 million and no debt. Though, to shore things up, it has announced a $30 million multicurrency revolving credit facility from HSBC.

Management commentary

Nuix CEO, Jonathan Rubinsztein, commented:

During the half, the Nuix team has not only delivered on further momentum in top line growth, but also made significant progress on our core strategic growth initiative, Nuix Neo. We have continued to drive growth in ACV and Statutory Revenue, while remaining focused on costs, contributing to further growth in Underlying EBITDA. Commercial relationships with our customers remain strong, as evidenced by further momentum in our NDR and generally low churn.

Outlook

Failing to stop the Nuix share price from sinking today is news that the company has reaffirmed its targets for FY 2024.

This includes ~10% ACV and statutory revenue growth in constant currency, revenue growth exceeding underlying cost growth, and being underlying cash flow positive for the year.

The Nuix share price is still up 58% over the last 12 months following today's weakness.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

cochlear happy, share price rise, up, increase
Earnings Results

Why are Cochlear shares flying 7% higher today?

Now Cochlear must turn product momentum into sustained growth and recover lost investor confidence.

Read more »

Male Lab Worker Wearing White Coat Recording Test Results On Computer.
Earnings Results

CSL shares surge 18% as 'reset year' points to a return to growth

Investors welcome CSL’s results and outlook after a very difficult reset year.

Read more »

Australian notes and coins symbolising dividends.
Financial Shares

WAM Leaders lifts dividend as portfolio outperforms in FY26

WAM Leaders lifts its fully franked dividend after beating the ASX 200 with a strong FY2026 result.

Read more »

Man lying down on sofa and trading on his laptop.
Industrials Shares

SKS Technologies reports record FY26 earnings

SKS Technologies reports record-breaking earnings for FY26, driven by strong revenue growth and major project wins in the data centre…

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Earnings Results

Pro Medicus FY26: Strong earnings growth and higher dividend

It was another strong year for this healthcare technology company.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Industrials Shares

Sims delivers strong FY26 earnings growth as AI demand fuels SLS division

Underlying net profit swung from a loss in FY 2025 to a $289.1 million profit in FY 2026.

Read more »

A young man clasps his hand to his head with a pained expression on his face and a laptop in front of him.
Retail Shares

Why the JB Hi-Fi share price just suffered its worst day on record

How will the retailer's shares respond today?

Read more »

A man stares out of an office window onto a landscape of high rise office buildings in an urban landscape.
REITs

HealthCo Healthcare & Wellness REIT reveals FY26 earnings, maps out dividend restart

Dividends could return in FY 2027 according to the release.

Read more »